Literature DB >> 27105909

Heparin interactions with apoA1 and SAA in inflammation-associated HDL.

Andreas Digre1, Jie Nan2, Martin Frank3, Jin-Ping Li4.   

Abstract

Apolipoprotein A1 (apoA1) is the main protein component responsible for transportation of cholesterol on high-density lipoprotein (HDL). Serum amyloid A (SAA) is an acute phase protein associated with HDL. Apart from their physiological functions, both apoA1 and SAA have been identified as 'amyloidogenic peptides'. We report herein that the polysaccharide heparin interacts with both apoA1 and SAA in HDL isolated from plasma of inflamed mice. The reaction is rapid, forming complex aggregates composed of heparin, apoA1 and SAA as revealed by gel electrophoresis. This interaction is dependent on the size and concentration of added heparin. Mass spectrometry analysis of peptides derived from chemically crosslinked HDL-SAA particles detected multiple crosslinks between apoA1 and SAA, indicating close proximity (within 25 Å) of these two proteins on the HDL surface, providing a molecular and structural mechanism for the simultaneous binding of heparin to apoA1 and SAA.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Amyloid; Atherosclerosis; Heparan sulfate; Lipoproteins/receptors; Mass spectrometry; Proteoglycans

Mesh:

Substances:

Year:  2016        PMID: 27105909     DOI: 10.1016/j.bbrc.2016.04.092

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

1.  Differentially expressed serum host proteins in hepatitis B and C viral infections.

Authors:  Kruti Dalal; Priyanka Khorate; Bhavik Dalal; Rahul Chavan; Shobna Bhatia; Avinash Kale; Akash Shukla; Aruna Shankarkumar
Journal:  Virusdisease       Date:  2018-09-01

2.  Paradoxical effects of SAA on lipoprotein oxidation suggest a new antioxidant function for SAA.

Authors:  Shobini Jayaraman; Christian Haupt; Olga Gursky
Journal:  J Lipid Res       Date:  2016-10-15       Impact factor: 5.922

Review 3.  Serum amyloid A - a review.

Authors:  George H Sack
Journal:  Mol Med       Date:  2018-08-30       Impact factor: 6.354

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.